# A Study to Evaluate the Safety and Immunogenicity of an Investigational Vaccine for Chronic Hepatitis B Virus Infection, in Healthy Adults

> **NCT06989788** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **AstriVax Therapeutics** · enrollment: 16 (actual)

## Conditions studied

- Chronic Hepatitis b

## Interventions

- **BIOLOGICAL:** AVX70371
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06989788
- **Lead sponsor:** AstriVax Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-05-06
- **Primary completion:** 2026-08-31
- **Final completion:** 2026-08-31
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06989788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06989788, "A Study to Evaluate the Safety and Immunogenicity of an Investigational Vaccine for Chronic Hepatitis B Virus Infection, in Healthy Adults". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06989788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*